Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study.

MLA

Watanabe, Kenichiro, et al. “Feasibility of Dose-Dense Cisplatin-Based Chemotherapy in Japanese Children with High-Risk Hepatoblastoma: Analysis of the JPLT3-H Pilot Study.” Pediatric Blood & Cancer, vol. 69, no. 2, Feb. 2022, p. e29389. EBSCOhost, https://doi.org/10.1002/pbc.29389.

APA

Watanabe, K., Mori, M., Hishiki, T., Yokoi, A., Ida, K., Yano, M., Fujimura, J., Nogami, Y., Iehara, T., Hoshino, K., Inoue, T., Tanaka, Y., Miyazaki, O., Takimoto, T., Yoshimura, K., & Hiyama, E. (2022). Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study. Pediatric Blood & Cancer, 69(2), e29389. https://doi.org/10.1002/pbc.29389

Chicago

Watanabe, Kenichiro, Makiko Mori, Tomoro Hishiki, Akiko Yokoi, Kohmei Ida, Michihiro Yano, Junya Fujimura, et al. 2022. “Feasibility of Dose-Dense Cisplatin-Based Chemotherapy in Japanese Children with High-Risk Hepatoblastoma: Analysis of the JPLT3-H Pilot Study.” Pediatric Blood & Cancer 69 (2): e29389. doi:10.1002/pbc.29389.